The role of carbon dioxide detection in the prevention of sick building syndrome

Health & safety

The role of carbon dioxide detection in the prevention of sick building syndrome

13 Aug, 2019

Published over 7 years ago. See the latest and most current information on Health & safety.

Poor ventilation and high carbon dioxide levels in buildings where people work or live can result in people feeling unwell or suffering from a range of illness symptoms. Common ailments can include headaches, shortness of breath or eye irritations. Often people can feel ill for no apparent reason. This could be the result of Sick Building Syndrome (SBS) and typically, the symptoms disappear following the departure of the sufferer from the building.

In buildings where SBS is having a detrimental effect on its occupants, it is vital that measures are taken to prevent the syndrome.

In an attempt to alleviate the problem and promote best working practices, the Health and Safety Executive recommend the ventilation and on-going maintenance of ventilation equipment. They also highlight that one of the challenges in diagnosing SBS is that polluting chemicals and gases may be present at an exposure level which is lower than the current occupational limits which can mean that sampling could be difficult.

In this article Edinburgh Sensors discusses the monitoring of carbon dioxide levels as an important part of managing SBS which requires continual online gas analysis with high sensitive detectors.

Read the full article online at Edinburgh Sensors.

Latest News

IET Guide 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Portable fluorescence reader could bring forward molecular tests for use at home
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
Vietnam’s E10 rollout puts fuel testing capacity under closer scrutiny
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow